Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

LXEOLXEO
Showing 3 of 5 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in LEXEO THERAPEUTICS INC

Qube Research & Technologies Ltd holds 1.4M shares of LXEO (LEXEO THERAPEUTICS INC), worth $6.4M as of 2026-Q2. The position was increased (+195.6% shares). LXEO represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$6.4M

Current Shares

1.4M

Total Value Change

+$5.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+195.6%
$6.4M0.0%$4.66
44
2026-Q1
Increased
465,515
+249.3%
$2.7M0.0%$7.07
42
2025-Q4
New
133,257
-
$1.3M0.0%$9.74
35

Other major holders of LXEO: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used